Informatie:
Fout:
ID
13757
Beschrijving
Study of Sapacitabine in Acute Myeloid Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT01211457
Link
https://clinicaltrials.gov/show/NCT01211457
Trefwoorden
Versies (1)
- 03-03-16 03-03-16 -
Houder van rechten
CC BY-NC 3.0
Geüploaded op
3 maart 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC-ND 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Acute Myeloid Leukemia NCT01211457
Eligibility Acute Myeloid Leukemia NCT01211457
- StudyEvent: Eligibility
Similar models
Eligibility Acute Myeloid Leukemia NCT01211457
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
de novo aml
Item
newly diagnosed aml based on who classification
boolean
C0023467 (UMLS CUI [1,1])
C1515568 (UMLS CUI [1,2])
C1515568 (UMLS CUI [1,2])
age and chemotherapy regimen
Item
age 70 years or older for whom the treatment of choice is low-intensity therapy by investigator assessment or who has refused intensive induction therapy recommended by investigator
boolean
C0001779 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C0392920 (UMLS CUI [2])
ECOG
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
renal function
Item
adequate renal function
boolean
C0232804 (UMLS CUI [1])
liver function
Item
adequate liver function
boolean
C0232741 (UMLS CUI [1])
capsules
Item
able to swallow capsules
boolean
C0006935 (UMLS CUI [1])
informed consent form
Item
ability to understand and willingness to sign the informed consent form
boolean
C0021430 (UMLS CUI [1])
APL or extramedullary myeloid tumor
Item
aml is of the sub-type of acute promyelocytic leukemia or extramedullary myeloid tumor without bone marrow involvement
boolean
C0023487 (UMLS CUI [1])
C2939461 (UMLS CUI [2,1])
C1517060 (UMLS CUI [2,2])
C2939461 (UMLS CUI [2,1])
C1517060 (UMLS CUI [2,2])
prior therapy for aml
Item
having received any systemic anti-cancer therapy for aml or received treatment with hypomethylating agents or cytotoxic chemotherapy for the preceding mds or mpd
boolean
C0023467 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C2613367 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0392920 (UMLS CUI [3])
C3463824 (UMLS CUI [4])
C1514463 (UMLS CUI [1,2])
C2613367 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0392920 (UMLS CUI [3])
C3463824 (UMLS CUI [4])
cns leukemia
Item
known central nervous system (cns) involvement by leukemia
boolean
C1332884 (UMLS CUI [1])
comorbidity
Item
uncontrolled intercurrent illness including
boolean
C0009488 (UMLS CUI [1])
hypersensitivity to decitabine
Item
known hypersensitivity to decitabine
boolean
C0049065 (UMLS CUI [1,1])
C0020517 (UMLS CUI [1,2])
C0020517 (UMLS CUI [1,2])
hiv
Item
known to be hiv-positive
boolean
C0019682 (UMLS CUI [1])